sing electronic nose measurements to capture subgroups of children with asthma. - Electronic nose measurements in children

Academisch Medisch Centrum0 个研究点目标入组 75 人开始时间: 待定最近更新: 2024年4月29日

适应症

试验速览

暂无简介。

•General inclusion criteria:
•- Males and females aged 6 to 17 years
•- Parent / guardian must be able to give written informed consent prior to participation in the study, which includes ability to comply with the requirements and restrictions listed in the consent form. Informed consent must be obtained prior to undertaking any study procedures.
•- Assent should be obtained from all children in the study where appropriate.;For patients with asthma:
•- Diagnosis of asthma given by specialists (data documented in patient records) according to the GINA guidelines.

•- Known underlying respiratory tract disease like congenital airway abnormalities, cystic fibrosis, primary ciliary dyskinesia, bronchopulmonary dysplasia or bronchiectasis.
•- Known systemic or inflammatory diseases.
•- History or current evidence of an upper or lower respiratory infection or symptoms (including common cold) within 2 weeks of baseline assessment (assessment should be deferred).
•- The child has had a exacerbation (requiring ER attendance or hospital admission and /or a course of high dose OCS for at least 3 days duration) within 4 weeks of the baseline assessment (assessment should be deferred).

发起方